生物药物治疗eosinophilic COPD:目前的应用和未来的前景
Qi Qi1, Wenbei Peng1, Bohan Yang1
1Department of Pulmonary and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in immunology
|March 16, 2026
概括
异性慢性阻塞性肺病 (COPD) 涉及2型炎症,需要新的生物疗法. 鉴定这种炎症的生物标志物是有效治疗eosinophilic COPD患者的关键.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂的肺部疾病,通常与1型免疫有关.
- 一个独特的COPD患者小组表现出eosinophilic炎症 (类型 2),尽管标准的三重疗法仍然存在.
- 这突出了针对异性慢性肺炎的向治疗的未满足需求.
研究的目的:
- 审查针对2型炎症的eosinophilic COPD的新兴生物疗法.
- 讨论生物标志物在识别和管理COPD表型中的关键作用和未来潜力.
主要方法:
- 对当前和新兴生物制剂的文献综述.
- 对调查COPD2型炎症标志物的研究进行分析.
- 综合关于生物药物和生物标志物的疗效和应用的数据.
主要成果:
- 一些针对2型细胞因子 (IL-5,IL-4,IL-13) 和警示素 (IL-33,TSLP) 的单克隆抗体对异性慢性肺炎有希望.
- 生物标志物对于准确的患者分层和监测治疗反应至关重要.
- 针对性疗法的开发正在推进,但生物标志物验证仍在进行中.
结论:
- 针对2型路径的生物药物代表了治疗eosinophilic COPD的重大进展.
- 准确和可访问的生物标志物对于这些新疗法的临床实施至关重要.
- 需要进行进一步的研究,以优化生物标志物的使用,并为患有2型炎症的COPD患者个性化治疗策略.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:20Asthma: Pathogenesis and Management
1.6K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K